|国家科技期刊平台
首页|期刊导航|中国脑血管病杂志|高密度脂蛋白胆固醇与急性缺血性卒中静脉溶栓后出血转化相关性研究进展

高密度脂蛋白胆固醇与急性缺血性卒中静脉溶栓后出血转化相关性研究进展OA北大核心CSTPCD

Progress of the correlation between high-density lipoprotein cholesterol and hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke

中文摘要英文摘要

缺血性卒中是最常见的脑血管病类型,是全球范围死亡和残疾的主要原因,占我国全部卒中的80%以上.近20 年来缺血性卒中的年龄标准化发病率和患病率分别增加了34.7%和33.5%.应用重组组织型纤溶酶原激活剂静脉溶栓治疗是发病时间窗内急性缺血性卒中(AIS)患者的标准治疗方式,但也面临着出血转化的风险.出血转化作为AIS再通治疗的一项严重并发症,在一定程度上阻碍了静脉溶栓在临床的推广应用,特别是中重度AIS常伴随出血转化风险增加.探索可早期识别出血转化高风险卒中患者的危险因素及风险模型构建是近些年的研究热点.近年来有研究发现,高密度脂蛋白胆固醇(HDL-C)水平升高与AIS静脉溶栓后出血转化发生风险增加密切相关.该文对HDL-C水平与AIS患者静脉溶栓后出血转化相关性的研究进展进行了综述,并就其可能的机制进行初步探讨,以期为相关研究领域提供一定的理论依据.

Ischemic stroke is the most common type of cerebrovascular disease,serving as a primary cause of global mortality and disability,and accounting for over 80%of all strokes in China.Over the past two decades,the age-standardized incidence and prevalence of ischemic stroke have increased by 34.7%and 33.5%,respectively.The standard treatment for acute ischemic stroke(AIS)patients within the onset time window is the use of recombinant tissue-type plasminogen activator(rt-PA)for intravenous thrombolysis,but it comes with the risk of hemorrhagic transformation.Hemorrhagic transformation,as a severe complication of AIS reperfusion therapy,has impeded the widespread clinical application of intravenous thrombolysis to some extent,particularly in moderate to severe AIS cases where the risk of hemorrhagic transformation is elevated.Exploring the risk factors and constructing risk models for the early identification of high-risk stroke patients for hemorrhagic transformation has been a recent research focus.In recent years,studies have found a close association between elevated levels of high-density lipoprotein cholesterol(HDL-C)and increased risk of hemorrhagic transformation following AIS intravenous thrombolysis.This paper provides a review of the research progress on the correlation between HDL-C levels and hemorrhagic transformation after intravenous thrombolysis in AIS patients,and initiates a preliminary discussion on possible mechanisms,aiming to provide a theoretical basis for further research in the related field.

王欣;吴小三;胡轶阳;张骏

230601 合肥,安徽医科大学第二附属医院神经内科安徽医科大学第二临床医学院

胆固醇,HDL卒中急性缺血性卒中溶栓治疗出血转化综述

Cholesterol,HDLStrokeIschemic strokeThrombolytic therapyHemorrhagic transformationReview

《中国脑血管病杂志》 2024 (002)

130-137 / 8

安徽省自然科学基金(2108085QH331);安徽医科大学第二附属医院国家自然科学基金孵育计划项目(2020GQFY02)

10.3969/j.issn.1672-5921.2024.02.008

评论